BPC-157
10 mg vial, 60 capsules
Is retatrutide available in Australia? As an approved medicine, no. You will not find it on the Australian Register of Therapeutic Goods, no pharmacy shelf holds it, and no GP can write a script for it as an approved product. Two doors are open today. People can reach it through clinical trials, and laboratories can buy it as a research chemical.
Eli Lilly is developing retatrutide, and it remains investigational. No regulator anywhere, the TGA and US FDA included, had signed off on it at the time of writing, and the ARTG has no record for it. Through 2026 the TGA issued warnings on unapproved peptides naming retatrutide, with GHK-Cu, CJC-1295, TB-500 and BPC-157 also called out, and it stressed that retatrutide belongs only inside a clinical trial.
Real cases sat behind those warnings. Six cases of acute liver injury came to light in June 2026, reported by the Victorian Department of Health and connected to unapproved products carrying the retatrutide name (street labels included "Reta", "R-10" and "R-20"). Investigators suspected a contaminant. Three months on, in September 2026, a torn oesophagus put a patient in hospital, and when the TGA analysed the product involved, which was labelled retatrutide, there was no retatrutide present at all. What it contained was a large undeclared dose of semaglutide. The TGA has added that printing "research use only" on a pack changes nothing about its regulatory position once the goods are promoted or supplied for use in people.
You cannot buy retatrutide at Chemist Warehouse, and the same holds for every other pharmacy in the country. A pharmacist is limited to ARTG-registered medicines plus anything covered by a specific exemption, and retatrutide fits neither category. Treat any chemist listing for retatrutide as fake. AminoLab is not affiliated with Chemist Warehouse or any other pharmacy group.
Prescription incretins that pharmacists do hand over are other molecules entirely, Mounjaro (tirzepatide) plus Ozempic and Wegovy (semaglutide). For how these compare with retatrutide, see our retatrutide vs tirzepatide comparison.
No one knows the date, and a confident answer is a guess. These are the facts on record.
Tirzepatide offers a useful precedent. Mounjaro (tirzepatide) gained Australian registration for type 2 diabetes toward the end of 2022, and only in September 2024 did the TGA add chronic weight management, some time after the American approvals. On that pattern, retatrutide is unlikely to become an approved Australian medicine before the FDA rules, and what happens next turns on when Lilly lodges an application and how the TGA review unfolds. An ARTG listing would not bring PBS subsidy either, since that is a separate process.
If you want to know how to get retatrutide in Australia as a person, a clinical trial is the only approved path right now. Lilly's programme has used Australian sites. The heart and kidney outcomes study, TRIUMPH-Outcomes, has listed Australian centres including The Alfred, Box Hill Hospital, Fiona Stanley Hospital, Canberra Hospital, Royal North Shore Hospital, Royal Brisbane and Women's Hospital, and the Charles Perkins Centre at the University of Sydney. Several of the local studies have closed enrolment.
Two registers cover retatrutide trial sign-up in Australia. One is ClinicalTrials.gov, filtered by country. The other is australianclinicaltrials.gov.au, the national Australian Clinical Trials site fed by the ANZCTR register. Places are allocated by each study team under tight eligibility rules, so ask your GP or specialist to help you weigh up any open study.
Research supply is the second legitimate channel. Labs and research groups can order retatrutide from AminoLab as a chemical reagent for bench and in vitro studies. It is not a medicine and is not for human use, and orders are restricted to adults 18+. It ships as lyophilised powder (10 mg, 20 mg or 30 mg vials) or as a 10 mg research pen already in solution.
Pick the format that fits the project. The lyophilised retatrutide vials come in 10, 20 and 30 mg, and the bigger fills bring the cost per milligram down for longer studies. The retatrutide starter kit can be built around whichever vial size you choose, and the pen suits labs that would rather skip reconstitution. Everything ships from Australian stock and comes with an independent certificate matched to its lot. Shop retatrutide online here, and if you order a vial, put bacteriostatic water in the same cart.
The Victorian liver cases and the TGA's semaglutide result point to the same lesson. With retatrutide the biggest danger is not knowing what the vial really holds. Whichever supplier you rate as the best place to buy retatrutide in Australia for research, run through this list first.
AminoLab sends each lot to an outside laboratory that runs HPLC for purity and mass spectrometry for identity. The full process is described on our quality testing page, and the walkthrough on reading a certificate of analysis shows what a real report looks like.
Mixing a vial? The retatrutide reconstitution calculator does the arithmetic, and related compounds sit in our metabolic research peptide range. Our entire catalogue is supplied for laboratory research alone, never for human or veterinary use. Our research use only policy applies to every order, so read it first.
No. There is no ARTG record and no TGA approval, so it cannot legally reach patients as a prescribed medicine. A registered clinical trial is the only route open to people here. Separately, laboratories can buy it as a research chemical, strictly for research and never for human use.
Not yet. Lilly's US filing is slated for Q1 2027. For Australia, a separate TGA dossier and review would be required, and Lilly has given no local timeline. As a rough guide, tirzepatide's weight management approval here arrived after its US approval.
It does not. Chemist Warehouse, along with every other Australian pharmacy, can dispense only registered medicines, and retatrutide is unregistered, so no pharmacy here sells it. Scripts for Mounjaro or Ozempic can be filled there, yet those products are tirzepatide and semaglutide, not retatrutide.
Two registers list studies, australianclinicaltrials.gov.au and ClinicalTrials.gov (set the country filter to Australia). Lilly has run studies at Australian hospitals and research centres, although several are no longer recruiting. Each study screens applicants closely, and your doctor is the right person to discuss suitability with.
Not as of September 2026. Lilly has announced positive phase 3 readouts from several TRIUMPH and TRANSCEND studies, and a July 2026 update moved the US filing to Q1 2027. Approval, if granted, would only follow the FDA review that comes after lodgement.
Order from AminoLab online. For lab research we stock lyophilised vials in three sizes (10, 20 or 30 mg), a starter kit, and a 10 mg pen with 3 mL of solution, every item sent from stock held in Australia. Each batch carries an external lab report on identity and purity. It is not a medicine, is not TGA approved and is not sold for human use.
10 mg vial, 60 capsules
50 mg vial, 100 mg vial
10 mg vial
3 mL, 3 mL + 1 syringe, 10 mL, 10 mL + 1 syringe, 30 mL, 30 mL + 1 syringe
Research use onlyAminoLab supplies research compounds for laboratory and in-vitro use, not for human or animal consumption. By continuing you confirm you are 18 or older and buying for research.
Leave